Ruof, Joerg; Schwartz, Friedrich Wilhelm; Schulenburg, Johann-Matthias Graf von der; Dintsios, Charalabos-Markos
(New York : Springer, 2014)
Since the introduction of the German health care reform in January 2011, an early benefit assessment (EBA) is required for all new medicines. Pharmaceutical manufacturers have to submit a benefit dossier for evaluation by ...